Approval · Notice of Compliance 26406 · 2021
HYDREA: Notice of Compliance 26406
Issued August 11, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26406
- Date
- August 11, 2021
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- 1) To update the Product Monograph (PM) to include hemolytic; (2) To update the non-medicinal ingredients list; and (3) Migrate the PM to the 2020 format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDREA | Not yet assigned | — |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP